Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 8 studies | 19% ± 3% | |
epithelial cell | 5 studies | 31% ± 15% | |
fibroblast | 4 studies | 27% ± 14% | |
GABAergic neuron | 4 studies | 37% ± 12% | |
oligodendrocyte | 4 studies | 24% ± 4% | |
neuron | 3 studies | 23% ± 4% | |
ciliated cell | 3 studies | 24% ± 5% | |
glutamatergic neuron | 3 studies | 50% ± 5% | |
dendritic cell | 3 studies | 23% ± 9% | |
goblet cell | 3 studies | 23% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 36% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 8825.52 | 258 / 258 | 100% | 55.10 | 230 / 230 |
esophagus | 100% | 5266.31 | 1445 / 1445 | 100% | 73.42 | 183 / 183 |
stomach | 100% | 3478.03 | 359 / 359 | 100% | 54.27 | 286 / 286 |
breast | 100% | 5392.83 | 459 / 459 | 100% | 81.19 | 1117 / 1118 |
lung | 100% | 5229.72 | 578 / 578 | 100% | 57.01 | 1152 / 1155 |
uterus | 100% | 5540.46 | 170 / 170 | 100% | 50.21 | 457 / 459 |
ovary | 99% | 3634.09 | 179 / 180 | 100% | 49.11 | 430 / 430 |
pancreas | 100% | 3230.95 | 328 / 328 | 99% | 46.48 | 177 / 178 |
prostate | 100% | 4985.30 | 244 / 245 | 100% | 71.31 | 501 / 502 |
brain | 99% | 4377.05 | 2624 / 2642 | 100% | 62.68 | 705 / 705 |
intestine | 100% | 4940.91 | 966 / 966 | 99% | 46.41 | 523 / 527 |
thymus | 100% | 4570.28 | 651 / 653 | 99% | 53.65 | 601 / 605 |
liver | 100% | 3815.69 | 226 / 226 | 99% | 44.73 | 402 / 406 |
bladder | 100% | 5328.14 | 21 / 21 | 99% | 44.06 | 498 / 504 |
kidney | 100% | 3058.89 | 89 / 89 | 98% | 44.91 | 887 / 901 |
skin | 100% | 5668.75 | 1806 / 1809 | 97% | 62.22 | 457 / 472 |
adipose | 100% | 6539.75 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9231.66 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 7738.12 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3114.09 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 48.56 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.93 | 1 / 1 |
heart | 96% | 4300.12 | 827 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 20.77 | 27 / 29 |
eye | 0% | 0 | 0 / 0 | 88% | 37.21 | 70 / 80 |
peripheral blood | 57% | 1322.62 | 525 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0009791 | Biological process | post-embryonic development |
GO_0042733 | Biological process | embryonic digit morphogenesis |
GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
GO_0030204 | Biological process | chondroitin sulfate metabolic process |
GO_0001958 | Biological process | endochondral ossification |
GO_0002063 | Biological process | chondrocyte development |
GO_0001501 | Biological process | skeletal system development |
GO_0012505 | Cellular component | endomembrane system |
GO_0016020 | Cellular component | membrane |
GO_0005796 | Cellular component | Golgi lumen |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0032588 | Cellular component | trans-Golgi network membrane |
GO_0016604 | Cellular component | nuclear body |
GO_0005829 | Cellular component | cytosol |
GO_0008254 | Molecular function | 3'-nucleotidase activity |
GO_0008441 | Molecular function | 3'(2'),5'-bisphosphate nucleotidase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0097657 | Molecular function | 3',5'-nucleotide bisphosphate phosphatase activity |
Gene name | BPNT2 |
Protein name | 3'(2'), 5'-bisphosphate nucleotidase 2 Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase (Golgi-resident PAP phosphatase) (gPAPP) (EC 3.1.3.7) (3'(2'), 5'-bisphosphate nucleotidase 2) (Inositol monophosphatase domain-containing protein 1) (Myo-inositol monophosphatase A3) (Phosphoadenosine phosphate 3'-nucleotidase) |
Synonyms | IMPAD1 IMPA3 |
Description | FUNCTION: Exhibits 3'-nucleotidase activity toward adenosine 3',5'-bisphosphate (PAP), namely hydrolyzes adenosine 3',5'-bisphosphate into adenosine 5'-monophosphate (AMP) and a phosphate. May play a role in the formation of skeletal elements derived through endochondral ossification, possibly by clearing adenosine 3',5'-bisphosphate produced by Golgi sulfotransferases during glycosaminoglycan sulfation. Has no activity toward 3'-phosphoadenosine 5'-phosphosulfate (PAPS) or inositol phosphate (IP) substrates including I(1)P, I(1,4)P2, I(1,3,4)P3, I(1,4,5)P3 and I(1,3,4,5)P4. . |
Accessions | ENST00000517461.1 H0YB38 ENST00000520392.1 H0YBS3 ENST00000262644.9 Q9NX62 |